Neuro-Oncology
Chemotherapy: neurologic complications
Jul. 25, 2025
Patrick Y Wen MD
Associate Professor of Neurology
Harvard Medical School
Director of Neuro-oncology
Department of Neurology
Brigham and Women's Hospital
Contributor Disclosures
Dr. Wen of Harvard Medical School, Dana-Farber Cancer Institute, and Brigham and Women’s Hospital received research grants from Astra Zeneca, Black Diamond, Bristol Meyers Squibb, Chimerix, Eli Lily, Erasca, Global Coalition for Adaptive Research, Kazia, MediciNova, Merck, Novartis, Quadriga, Servier, and VBI Vaccines. He received advisory board membership honoraria/consulting fees from Astra Zeneca, Black Diamond, Celularity, Chimerix, Day One Bio, Fore Biotherapeutics, Genenta, Glaxo Smith Kline, Kintara, Merck, Mundipharma, Nerviano Medical Sciences, Novartis, Novocure, Sapience, Servier, Tango, Telix, and VBI Vaccines.